Jeffery Stolte

Jeffery Stolte has extensive experience in the venture capital and healthcare industry. Jeffery began their career in 2012 as a Board Observer at GetWellNetwork, and later served as a Board Director at InDemand Interpreting, Binary Fountain™, and Intelligent Retinal Imaging Systems - IRIS. In 2014, they joined Providence Ventures as a Partner, where they were responsible for building the organization's first venture capital fund and leading the investment team. In 2018, they were promoted to Senior Partner and successfully launched Providence Ventures Fund II, managing $300 million across two investment funds. Jeffery has also served on the boards of Trilliant Health, Protenus, and Trilliant Health. Currently, they are a Board Director at Kno2 and SpineZone. Jeffery Stolte's contributions have played a critical role in the healthcare transformation vision of Providence Ventures.

Jeffery Stolte received an A.B. degree in BioPsychology from the University of Chicago in 1994. Jeffery then pursued a Master of Science (M.S.) degree in Biomedical Informatics from Oregon Health & Science University from 1996 to 1998. Later, from 2006 to 2008, Jeffery Stolte attended The University of Chicago Booth School of Business, where they earned a Master of Business Administration (MBA) degree.